Facebook Twitter Linkedin Google Plus

Improving Outcomes in the Treatment of Breast Cancer (Video)

Improving Outcomes in the Treatment of Breast Cancer (Video) +

Over the last 25 years, there has been an explosion of new and vitally important, anticancer drugs. The development of these promising new therapeutic agents is generally based on preclinical and clinical research. In many cases, this research has become prohibitively expensive. And only a relatively few investigational drugs have reached the market and have successfully improved clinical outcomes in the treatment of patients with cancer and hematological malignancies. Over the last few decades scientists have tried to change – and improve – the way clinical trials are conducted. But it still takes many years and huge investments to successfully bring a new drug to market. And despite their efforts there is still a huge unmet medical need. What needs to change? How can we improve the development of novel anticancer drugs? Watch the 3rd episode in "Changing Strategies in the War in Cancer."

Read more

ASH 2016: Highlighting Clinically Useful Information

ASH 2016: Highlighting Clinically Useful Information +

The upcoming 58th annual meeting of the American Society of Hematology, to be held in San Diego, CA, December 3 - 6, will be overflowing with interesting, informative, and clinically useful news and valuable research updates. The annual meeting is considered the world's premier event in malignant and non-malignant hematology and provides an invaluable educational experience and an opportunity to review thousands of scientific abstracts highlighting updates in the latest topics in hematology. The annual meeting also offers a great opportunity to network with top minds in the field, as well as a global community of more than 20,000 hematology professionals from every subspecialty.

Read more

Delivering Cures Through Science: AACR Presents Research Updates

Delivering Cures Through Science: AACR Presents Research Updates +

The Interaction and collaboration between scientist promotes and stimulates discovery leading to medical breakthroughs. This year the annual meeting of the American Association for Cancer Research in New Orleans (April 16 - 20) is expected to draw more than 19,000 scientists, clinicians, advocates, and others to discuss advances in the field of cancer science. The multidisciplinary program is expected to include nearly 100 papers and posters covering all aspects of antibody-drug conjugates - from early discovery to preclinical and clinical trials.

Read more

ASCO 2016: Revolutionizing Cancer Treatment and Care

ASCO 2016: Revolutionizing Cancer Treatment and Care +

It’s just a few more weeks until the start of the 2016 annual meeting of American Society of Clinical Oncology (ASCO). This year, the theme of the meeting is "Collective Wisdom: The Future of Patient-Centered Care and Research", emphasizing that the combined knowledge from various disciplines, cancer types, treatment approaches, and big data technologies is essential to progress. Among the more than 5,200 abstracts to be presented are a large number offering a better understanding of cancer biology and chemistry, focusing on targeted therapies and personalized/precision medicine including antibody-drug conjugates, PD-1's and BiTe's, to name a few. Read our overview and find out what to expect during the 2016 annual meeting.

Read more

ABT-414 Shows Encouraging Phase I Trial Results in EGFR Amplified, Recurrent Glioblastoma

ABT-414 Shows Encouraging Phase I Trial Results in EGFR Amplified, Recurrent Glioblastoma +

Initial results from an open label, Phase I study of ABT-414, an investigational antibody drug conjugate or ADC for the treatment of patients with epidermal growth factor receptor (EGFR) amplified, recurrent glioblastoma (GBM), shows no dose-limiting toxicities and frequent, reversible ocular toxicities. These results, were presented at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill.

Read more

News


View all

Editorial


View all


Latest Articles

Drugs and Drug Hunters

16 January, 2017

All products of the creative process are a reflection of the individual makeup of the inventors.  ...


View all

Expert Interview


View all

Must Read Articles


View all

How to Contribute

Featured Events

22 Mar
CPhI Southeast Asia

Join 5,500 key suppliers and buyers at CPhI Southeast Asia - the region's lead...

08 Mar
CPhI Istanbul | Turkey

CPhI Istanbul 2017: Discover the number one pharmaceutical event in the MENA r...


View all events


Newsletter sign up

To subscribe to our weekly newsletter please send us your email address...


Lonza

Go to top

ADC Review
is made possible by:

Stay in touch

Facebook Twitter Linkedin Google Plus

Skip to toolbar